Literature DB >> 22226983

Identification and validation of protein targets of bioactive small molecules.

Denis V Titov1, Jun O Liu.   

Abstract

Identification and validation of protein targets of bioactive small molecules is an important problem in chemical biology and drug discovery. Currently, no single method is satisfactory for this task. Here, we provide an overview of common methods for target identification and validation that historically were most successful. We have classified for the first time the existing methods into two distinct and complementary types, the 'top-down' and 'bottom-up' approaches. In a typical top-down approach, the cellular phenotype is used as a starting point and the molecular target is approached through systematic narrowing down of possibilities by taking advantage of the detailed existing knowledge of cellular pathways and processes. In contrast, the bottom-up approach entails the direct detection and identification of the molecular targets using affinity-based or genetic methods. A special emphasis is placed on target validation, including correlation analysis and genetic methods, as this area is often ignored despite its importance. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22226983      PMCID: PMC3714012          DOI: 10.1016/j.bmc.2011.11.070

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  102 in total

1.  Identification by functional cloning from a retroviral cDNA library of cDNAs for ribosomal protein L36 and the 10-kDa heat shock protein that confer cisplatin resistance.

Authors:  Ding-Wu Shen; Xing-Jie Liang; Toshihiro Suzuki; Michael M Gottesman
Journal:  Mol Pharmacol       Date:  2006-01-04       Impact factor: 4.436

2.  Triptolide binds covalently to a 90 kDa nuclear protein. Role of epoxides in binding and activity.

Authors:  Christine McCallum; Suzy Kwon; Penny Leavitt; Dong-Ming Shen; Wensheng Liu; Anne Gurnett
Journal:  Immunobiology       Date:  2007-04-11       Impact factor: 3.144

3.  Inhibition of eukaryotic translation initiation by the marine natural product pateamine A.

Authors:  Woon-Kai Low; Yongjun Dang; Tilman Schneider-Poetsch; Zonggao Shi; Nam Song Choi; William C Merrick; Daniel Romo; Jun O Liu
Journal:  Mol Cell       Date:  2005-12-09       Impact factor: 17.970

4.  Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast.

Authors:  Ainslie B Parsons; Andres Lopez; Inmar E Givoni; David E Williams; Christopher A Gray; Justin Porter; Gordon Chua; Richelle Sopko; Renee L Brost; Cheuk-Hei Ho; Jiyi Wang; Troy Ketela; Charles Brenner; Julie A Brill; G Esteban Fernandez; Todd C Lorenz; Gregory S Payne; Satoru Ishihara; Yoshikazu Ohya; Brenda Andrews; Timothy R Hughes; Brendan J Frey; Todd R Graham; Raymond J Andersen; Charles Boone
Journal:  Cell       Date:  2006-08-11       Impact factor: 41.582

5.  Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA.

Authors:  Daisuke Kaida; Hajime Motoyoshi; Etsu Tashiro; Takayuki Nojima; Masatoshi Hagiwara; Ken Ishigami; Hidenori Watanabe; Takeshi Kitahara; Tatsuhiko Yoshida; Hidenori Nakajima; Tokio Tani; Sueharu Horinouchi; Minoru Yoshida
Journal:  Nat Chem Biol       Date:  2007-07-22       Impact factor: 15.040

6.  Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors.

Authors:  Marcus Bantscheff; Dirk Eberhard; Yann Abraham; Sonja Bastuck; Markus Boesche; Scott Hobson; Toby Mathieson; Jessica Perrin; Manfred Raida; Christina Rau; Valérie Reader; Gavain Sweetman; Andreas Bauer; Tewis Bouwmeester; Carsten Hopf; Ulrich Kruse; Gitte Neubauer; Nigel Ramsden; Jens Rick; Bernhard Kuster; Gerard Drewes
Journal:  Nat Biotechnol       Date:  2007-08-26       Impact factor: 54.908

7.  An integrated platform of genomic assays reveals small-molecule bioactivities.

Authors:  Shawn Hoon; Andrew M Smith; Iain M Wallace; Sundari Suresh; Molly Miranda; Eula Fung; Michael Proctor; Kevan M Shokat; Chao Zhang; Ronald W Davis; Guri Giaever; Robert P St Onge; Robert P StOnge; Corey Nislow
Journal:  Nat Chem Biol       Date:  2008-07-11       Impact factor: 15.040

Review 8.  Proteolytic 18O-labeling strategies for quantitative proteomics.

Authors:  Masaru Miyagi; K C Sekhar Rao
Journal:  Mass Spectrom Rev       Date:  2007 Jan-Feb       Impact factor: 10.946

9.  The identification of an osteoclastogenesis inhibitor through the inhibition of glyoxalase I.

Authors:  Makoto Kawatani; Hideo Okumura; Kaori Honda; Naoki Kanoh; Makoto Muroi; Naoshi Dohmae; Masamichi Takami; Mitsuhiro Kitagawa; Yushi Futamura; Masaya Imoto; Hiroyuki Osada
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-11       Impact factor: 11.205

10.  Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease.

Authors:  Stephanie J Leuenroth; Dayne Okuhara; Joseph D Shotwell; Glen S Markowitz; Zhiheng Yu; Stefan Somlo; Craig M Crews
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-06       Impact factor: 11.205

View more
  11 in total

1.  Antifungal drug itraconazole targets VDAC1 to modulate the AMPK/mTOR signaling axis in endothelial cells.

Authors:  Sarah A Head; Wei Shi; Liang Zhao; Kirill Gorshkov; Kalyan Pasunooti; Yue Chen; Zhiyou Deng; Ruo-jing Li; Joong Sup Shim; Wenzhi Tan; Thomas Hartung; Jin Zhang; Yingming Zhao; Marco Colombini; Jun O Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-10       Impact factor: 11.205

2.  Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling.

Authors:  Sarah A Head; Jun O Liu
Journal:  J Vis Exp       Date:  2016-09-20       Impact factor: 1.355

3.  Design, synthesis and biological evaluation of photoaffinity probes of antiangiogenic homoisoflavonoids.

Authors:  Bit Lee; Wei Sun; Hyungjun Lee; Halesha Basavarajappa; Rania S Sulaiman; Kamakshi Sishtla; Xiang Fei; Timothy W Corson; Seung-Yong Seo
Journal:  Bioorg Med Chem Lett       Date:  2016-07-21       Impact factor: 2.823

4.  Identification of small molecule inhibitors of cytokinesis and single cell wound repair.

Authors:  Andrew G Clark; Jenny R Sider; Koen Verbrugghe; Gabriel Fenteany; George von Dassow; William M Bement
Journal:  Cytoskeleton (Hoboken)       Date:  2012-11-01

5.  Inhibition of Eukaryotic Translation by the Antitumor Natural Product Agelastatin A.

Authors:  Brandon McClary; Boris Zinshteyn; Mélanie Meyer; Morgan Jouanneau; Simone Pellegrino; Gulnara Yusupova; Anthony Schuller; Jeremy Chris P Reyes; Junyan Lu; Zufeng Guo; Safiat Ayinde; Cheng Luo; Yongjun Dang; Daniel Romo; Marat Yusupov; Rachel Green; Jun O Liu
Journal:  Cell Chem Biol       Date:  2017-04-27       Impact factor: 8.116

6.  Utilizing graph machine learning within drug discovery and development.

Authors:  Thomas Gaudelet; Ben Day; Arian R Jamasb; Jyothish Soman; Cristian Regep; Gertrude Liu; Jeremy B R Hayter; Richard Vickers; Charles Roberts; Jian Tang; David Roblin; Tom L Blundell; Michael M Bronstein; Jake P Taylor-King
Journal:  Brief Bioinform       Date:  2021-11-05       Impact factor: 11.622

Review 7.  Systematically Studying the Effect of Small Molecules Interacting with RNA in Cellular and Preclinical Models.

Authors:  Jessica A Bush; Christopher C Williams; Samantha M Meyer; Yuquan Tong; Hafeez S Haniff; Jessica L Childs-Disney; Matthew D Disney
Journal:  ACS Chem Biol       Date:  2021-06-24       Impact factor: 4.634

8.  DrugTargetSeqR: a genomics- and CRISPR-Cas9-based method to analyze drug targets.

Authors:  Corynn Kasap; Olivier Elemento; Tarun M Kapoor
Journal:  Nat Chem Biol       Date:  2014-06-15       Impact factor: 16.174

9.  Validation of the Target Protein of Insecticidal Dihydroagarofuran Sesquiterpene Polyesters.

Authors:  Lina Lu; Zhijun Qi; Qiuli Li; Wenjun Wu
Journal:  Toxins (Basel)       Date:  2016-03-18       Impact factor: 4.546

10.  Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition.

Authors:  Anja F Hohmann; Laetitia J Martin; Jessica L Minder; Jae-Seok Roe; Junwei Shi; Steffen Steurer; Gerd Bader; Darryl McConnell; Mark Pearson; Thomas Gerstberger; Teresa Gottschamel; Diane Thompson; Yutaka Suzuki; Manfred Koegl; Christopher R Vakoc
Journal:  Nat Chem Biol       Date:  2016-07-04       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.